David Michael Clark
CIK 1755662 · Chief People Officer · last filed 2026-04-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
FOLD price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
CRANBURY, NJ 08512
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Chief People Officer | 0 | $14.49 | $0 | -$2.03M | 32 | 2026-04-27 |
Recent Filings · Page 3 of 4
39 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-04 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +30,228 | -$247.8K | EDGAR |
| 2023-12-19 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Grant (A) | +8,212 | $0 | EDGAR |
| 2023-01-19 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −7,382 | -$99.7K | EDGAR |
| 2023-01-13 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +28,883 | -$225.2K | EDGAR |
| 2023-01-06 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | −24,199 | -$287.7K | EDGAR |
| 2023-01-04 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +33,733 | -$309.9K | EDGAR |
| 2022-10-11 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −5,510 | -$57.3K | EDGAR |
| 2022-08-09 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −11,322 | -$141.5K | EDGAR |
| 2022-01-19 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +78,622 | -$133.6K | EDGAR |
| 2022-01-04 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −20,637 | -$240.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.